Cargando…

Editorial: Neuronopathic lysosomal storage diseases - specific neuronal characteristics and therapeutic approaches

Detalles Bibliográficos
Autores principales:	Flunkert, Stefanie, Hutter-Paier, Birgit, Sun, Ying, Kehr, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681491/ https://www.ncbi.nlm.nih.gov/pubmed/36425219 http://dx.doi.org/10.3389/fnmol.2022.1078804

Ejemplares similares

Neuronopathic Gaucher disease: Beyond lysosomal dysfunction
por: Arévalo, Nohela B., et al.
Publicado: (2022)

Evaluation of Neuropathological Features in the SOD1-G93A Low Copy Number Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
por: Molnar-Kasza, Agnes, et al.
Publicado: (2021)

Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value
por: Loeffler, Tina, et al.
Publicado: (2020)

Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases
por: Jakóbkiewicz-Banecka, Joanna, et al.
Publicado: (2013)

Constant Levels of Tau Phosphorylation in the Brain of htau Mice
por: Neddens, Joerg, et al.
Publicado: (2020)

Hepatic and neuronal phenotype of NPC1(−/−) mice
por: Santiago-Mujica, Estibaliz, et al.
Publicado: (2019)

Quantification of Huntington’s Disease Related Markers in the R6/2 Mouse Model
por: Etxeberria-Rekalde, Estibaliz, et al.
Publicado: (2021)

Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease
por: Schiffer, Victoria, et al.
Publicado: (2020)

Decreased Plasma Aβ in Hyperlipidemic APP(SL) Transgenic Mice Is Associated with BBB Dysfunction
por: Löffler, Tina, et al.
Publicado: (2016)

Evaluating the effect of R-Baclofen and LP-211 on autistic behavior of the BTBR and Fmr1-KO mouse models
por: Sharghi, Shirin, et al.
Publicado: (2023)

Drug delivery for neuronopathic lysosomal storage diseases: evolving roles of the blood brain barrier and cerebrospinal fluid
por: Sato, Yuji, et al.
Publicado: (2022)

Non-Selective Calcium Channel Blocker Bepridil Decreases Secondary Pathology in Mice after Photothrombotic Cortical Lesion
por: Lipsanen, Anu, et al.
Publicado: (2013)

Modeling Lysosomal Storage Diseases in the Zebrafish
por: Zhang, T., et al.
Publicado: (2020)

Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients
por: Bhalla, Akhil, et al.
Publicado: (2020)

Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease
por: Hinteregger, Barbara, et al.
Publicado: (2021)

Leukotriene Signaling as a Target in α-Synucleinopathies
por: Strempfl, Katharina, et al.
Publicado: (2022)

Human iPSC-Based Models for the Development of Therapeutics Targeting Neurodegenerative Lysosomal Storage Diseases
por: Luciani, Marco, et al.
Publicado: (2020)

Stable Mutated tau441 Transfected SH-SY5Y Cells as Screening Tool for Alzheimer’s Disease Drug Candidates
por: Löffler, Tina, et al.
Publicado: (2012)

Neuroinflammation and related neuropathologies in APP(SL) mice: further value of this in vivo model of Alzheimer’s disease
por: Löffler, Tina, et al.
Publicado: (2014)

Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer’s disease and related murine models
por: Neddens, Joerg, et al.
Publicado: (2020)

Editorial: The molecular mechanisms of epilepsy and potential therapeutics
por: Engel, Tobias, et al.
Publicado: (2022)

Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses
por: Barone, Rita, et al.
Publicado: (2018)

The definition of neuronopathic Gaucher disease
por: Schiffmann, Raphael, et al.
Publicado: (2020)

Transgene integration causes RARB downregulation in homozygous Tg4–42 mice
por: Hinteregger, Barbara, et al.
Publicado: (2020)

Chaperone Therapy for Neuronopathic Lysosomal Diseases: Competitive Inhibitors as Chemical Chaperones for Enhancement of Mutant Enzyme Activities
por: Suzuki, Yoshiyuki, et al.
Publicado: (2009)

Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases
por: Favret, Jacob M., et al.
Publicado: (2020)

Editorial: From Whole-Cell to Single Synapse Engrams - Breaking the Code for Memory Formation, Storage and Recall
por: Cattaneo, Antonino, et al.
Publicado: (2022)

Editorial: Ion Channels: Therapeutic Targets for Neurological Disease
por: Hou, Panpan, et al.
Publicado: (2021)

Editorial: The protein kinase GSK3 in neurobiological functions and neuronal disorders
por: Plattner, Florian, et al.
Publicado: (2023)

CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges
por: Edelmann, Mariola J., et al.
Publicado: (2020)

Reproduction in Animal Models of Lysosomal Storage Diseases: A Scoping Review
por: Vuolo, Daniela, et al.
Publicado: (2021)

Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: A survey-based study
por: Koto, Yuta, et al.
Publicado: (2023)

Myeloid/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease
por: Sergijenko, Ana, et al.
Publicado: (2013)

Editorial: Protein Degradation, Aggregation, Membrane Trafficking and Exosomes in Neuronal Health and Disease
por: Campbell, Douglas S., et al.
Publicado: (2022)

Editorial: Molecular and Cellular Crosstalk on Neuronal Functionality and Regulation, From Development to Pathology
por: Segura, Inmaculada, et al.
Publicado: (2022)

Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
por: Amschl, David, et al.
Publicado: (2013)

Phosphorylation of different tau sites during progression of Alzheimer’s disease
por: Neddens, Joerg, et al.
Publicado: (2018)

Editorial: Molecular mechanisms in neural development, related disorders, and therapeutic treatments
por: Kumar, Vijay, et al.
Publicado: (2023)

Editorial: Stress, pain or drug addiction: epigenetics, biological mechanisms and therapeutics
por: Kim, Hee Young, et al.
Publicado: (2023)

A multifaceted evaluation of microgliosis and differential cellular dysregulation of mammalian target of rapamycin signaling in neuronopathic Gaucher disease
por: Zhang, Zhenting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m85of5ce7dl96ajmu0810ljf5e